TP53 and cancer: The results displayed that the altered genes in the high-risk subgroups belonged to pathways involving proteasome, cancer-muscle-contraction, glycosaminoglycan-biosynthesis-chondroitin-sulfate, p53-signaling-pathway, complement-and-coagulation-cascades (Figure 6A).